new and maintenance dialysis patients is about 68.8 years at present, and the ages are increasing every year. As a result, since 1983, the mean age has increased with overall rise of roughly 18-20 years by 2016.
Regarding to the main causes of ESRD, diabetic nephropathy has been increasing every year, and in 1998, diabetic nephropathy finally surpassed chronic glomerulonephritis (CGN) to become the main cause of ESRD. Currently, diabetic nephropathy accounts for 43.2% of all cases, but the increasing rate has been slowed and peaked. However, nephrosclerosis (hypertensive nephropathy) has been increasing gradually and accounted for 14.2% of the total. Nephrosclerosis will surpass CGN (16.6%) one of these days. 1 The aging of dialysis patients and changes in the main causes of ESRD are causing accelerated deterioration of not only the cardiovascular system but also the vascular access (VA) environment. 
Characteristic of VA modalities and condition in Japan

Comparison with other countries
The Dialysis Outcomes and Practice Patterns Study, which is an international comparison study introduced in 1996, indicates that VA modalities are an important factor in determining prognoses of hemodialysis patients and that the prognosis in Japan is one of the best worldwide. According to the data from DOPPS, uniquely in Japan, the use of native arteriovenous fistulae (AVF) accounts for 90% or more of VA modalities, a much higher percentage of the patients with AVF and a much lower percentage of patients with hemodialysis catheters than in other countries ( Figure 3 ). And more, the VA environment in the United States is in the opposite condition compared with Japan. In DOPPS II, percentage of arteriovenous graft (AVG) is very high (45%), and of AVF is very low (34%), but the percentage of AVF increased gradually due to the "Fistula first campaign" (Figure 4 ), 2 and it finally reached 68% and the AVG dropped to 18% in the DOPPS V (2012-2014). However, in United States, 68% of AVFs were created in the upper arm, only 32% were formed in the lower arm. In contrast, more than 90% of AVFs were created in the lower arm in Japan. 3 Thus, even in location of AVFs, there are major differences between Japan and other countries. So, we need to further consideration how these differences affect the prognosis of VA in the future. 4 
Vascular access condition from the data of JSDT
JSDT conducted the survey on VA condition at the end of 1998 and 2008. 5, 6 According to these data, about 90% or more of the dialysis patients have native AVFs, despite the age of new and maintenance dialysis patients getting older. However, the patients with AVGs have gradually increased from 4.8% to 7.1% over the past 10 years. In addition, it became clear that the percentage of AVGs increases with the prolongation of the dialysis duration. Figure 5 shows the relationship between the type of VA and the duration of dialysis. Among the patients on dialysis for less than 2 years, only 5.5% had AVGs. In contrast, 12.5% of the patients receiving dialysis for 25 years or more had such AVGs, which is a 2.3-fold increase percentage-wise. In these situations, the increasing tendency of AVGs means the deterioration of VA conditions in Japan, and suitable measures are required. According to JSDT guideline published in 2005 and revised in 2011, 7 percutaneous transluminal angioplasty (PTA) and its modified method is recommended as the first choice for treating VA stenosis. Since then, the number of PTA cases has been obviously increasing in Japan, even in our facility. And, PTA has become an important procedure for long-term maintenance of VA conditions.
Who plays the major role for VA creation and management in Japan?
The latest surveillance about VA in Japan collected data from 16,466 patients at 85 facilities was conducted by the Japanese Society for Dialysis Access (JSDA) in 2015.
According to the statistical data from JSDA, AVFs accounted for approximately 84% of VA modalities, while AVGs, superficialization of brachial artery, and hemodialysis catheter insertion were only performed in 9%, 3%, and 3% in Japan ( Figure 6 ). 8 In addition, JSDA also investigated what kind of doctors is involved in the preparation of VA and treatment of VA failure. Uniquely in Japan, about 60% of endovascular procedures (PTA) are conducted by dialysis specialists such as nephrologists and urologists who are well aware of the daily conditions of patient's VA. This trend is also the same as the data from JSDA, nephrologist who involved in dialysis is 39% and urologist is 20%. And, more than 90% of specialists are involved in dialysis treatment ( Figure 7) . 8 However, DOPPS shows VA Surgical Practices by Region and Phase from DOPPS II/III. The most characteristic feature in this field in Japan is that VA surgeries are conducted by nephrologists, urologists, and various surgeons who have different surgical specialties. In contrast, at least 80% of VA surgeries are conducted by vascular surgeons in North America and Europe. 9 The statistical data from JSDA also show that AVF and AVG creation procedures are mainly performed by dialysis specialists. In surgical creation of AVFs and AVGs, 58% and 52% of VA surgeries are conducted by nephrologists and urologists, respectively. In Japan, like this, the dialysis specialists (i.e. nephrologists and urologists) play a major role of VA creation and management in Japan. As mentioned above, the access environment in Japan is different from other countries and can be said to be a specific. Furthermore, although it is a personal opinion, it is difficult to say that the treatment method is varied at each facility or area and the training is standardized. Our next problem will be how to evaluate such a specific system of Japan and how to inherit it to the next generation.
Conclusion
We presented an overview of current state of dialysis condition and VA management in Japan. The outline of major contents is as follows:
1. The number of chronic dialysis patients was 329,609 (about 2600 persons per million in the population) at the end of 2016 in Japan. 2. The mean age of patients with newly initiated dialysis and that of patients already on dialysis were 69.4 and 68.2 years at the end of 2016. 3. The main cause of ESRD was diabetic nephropathy with an incidence rate of 43.7%. 4. In Japan, the dialysis patients of 97% or more were being treated by hemodialysis or hemodiafiltration. Therefore, careful daily management of VA is essential to better maintain the condition of HD patients. 5. JSDT Guidelines recommended PTA be the first choice for the treatment of VA stenosis, and has become an important procedure for long-term maintenance of the morphology and function of VA. 6. In Japan, approximately 60% of PTA procedures are conducted by dialysis specialists (such as nephrologists and urologists); in addition, AVF and AVG creation procedures are also performed by dialysis specialists. 7. However, the problems of how we evaluate the specificity of the Japanese system and pass it down the generations still remain.
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